Procurement Summary
Country: USA
Summary: Pr Needed New Request Tyroid Molecular Tests Thyroseq 5 Year Contract
Deadline: 30 Jun 2026
Posting Date: 13 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 143264468
Document Ref. No.: 36C26026Q0755
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Statement of Work/ Performance Work Statement
1. Contract Title.
Thyroid Molecular Testing
2. Background.
Thyroid nodules are common and require biopsy for diagnosis of a benign vs malignant
process. Fine needle aspiration cytology (FNA) is the biopsy method most frequently used to determine if a thyroid nodule is benign or malignant. Once assigned to the correct diagnostic category, a treatment plan can be prepared. If malignant, the treatment shall include a surgical procedure. Approximately 10% of the time the FNA diagnosis for a thyroid nodule shall be indeterminate for malignancy. These lesions are diagnosed: Follicular Lesion of Uncertain Significance (FLUS) or Follicular Neoplasm (FN). Thyroid nodules diagnosed on FNA as FLUS or FN may go on to surgery to determine the true nature of the nodule. Most thyroid nodules diagnosed FLUS or FN on FNA biopsy shall be found to be benign when the nodule is surgically removed. Therefore, many surgeries for thyroid nodules may not be necessary. Molecular testing of thyroid nodule FNA specimens was developed to aid in the diagnosis of indeterminate thyroid nodules. Molecular testing can detect hundreds of genes expressed in thyroid tissues. Reviewing thyroid-specific gene profiles can stratify thyroid nodule FNA specimens into those at low-risk (benign) and those at high-risk for malignancy.
3. Scope.
Molecular testing of thyroid nodule FNA specimens has been found to assist in the assessment of indeterminate thyroid nodules. Molecular testing can detect genetic alterations associated with thyroid malignancy. Molecular testing of an indeterminate thyroid nodule can stratify patients into those who may or may not need a surgical procedure. The Government has a requirement for molecular testing of indeterminate thyroid nodules at VA Puget Sound Health Care System (VAPSHCS) Seattle. This testing shall be performed at an outside laboratory. An FNA specimen from a thyroid nodule is placed into transport me...
Notice ID: 36c26026q0755
Department/Ind. Agency: veterans affairs, department of
Sub-tier: veterans affairs, department of
Office: 260-network contract office 20 (36c260)
Product Service Code: 6515 - medical and surgical instruments, equipment, and supplies
NAICS Code: 541380 - Testing Laboratories and Services
Inactive Dates: jul 15, 2026
Inactive Policy: manual
Documents
Tender Notice
Documents.zip